Anti-obesity jabs like semaglutide can lower heart attack and stroke risks in obese people regardless of weight loss. The drug may have other cardiovascular benefits beyond reducing body fat.
Study found similar reduction in cardiovascular events in obese patients on semaglutide, regardless of weight loss amount, suggesting the drug has additional mechanisms beyond weight reduction.
[
add
]
[
|
|
...
]